Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07604324
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisNovartis PharmaceuticalsNot Yet RecruitingPhase 1
NCT07604324Not Yet Recruiting
Phase 1
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Voluntee...Novartis Pharmaceuticals
NCT07601282
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction SurgeryShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruiting
NCT07601282Recruiting
—
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary...Shanghai General Hospital...
NCT07602140
TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.Shandong Provincial HospitalNot Yet RecruitingPhase 2
NCT07602140Not Yet Recruiting
Phase 2
TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-lin...Shandong Provincial Hospi...
NCT07601360
Nature-based Outdoor Activities for Promoting Stress Resilience in EmployeesThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07601360Completed
Not Applicable
Nature-based Outdoor Activities for Promoting Stress Resilience in EmployeesThe Chinese University of...
NCT07604649
TTM-Based Intervention for Weight Management Among High School Female StudentsUniversity of BaghdadNot Yet RecruitingNot Applicable
NCT07604649Not Yet Recruiting
Not Applicable
TTM-Based Intervention for Weight Management Among High School Female StudentsUniversity of Baghdad
NCT07601997
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)Myomed Technology (Shaoxing) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07601997Not Yet Recruiting
Not Applicable
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reper...Myomed Technology (Shaoxi...
NCT07603375
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal AdenocarcinomaDuke UniversityNot Yet RecruitingPhase 2
NCT07603375Not Yet Recruiting
Phase 2
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Lo...Duke University
NCT07603700
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary EmbolismNanjing First Hospital, Nanjing Medical UniversityNot Yet Recruiting
NCT07603700Not Yet Recruiting
—
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonar...Nanjing First Hospital, N...
NCT07603310
Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Patients.Hospital Dr. Franco Ravera ZuninoNot Yet RecruitingNot Applicable
NCT07603310Not Yet Recruiting
Not Applicable
Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Pat...Hospital Dr. Franco Raver...
NCT07605299
"Comparative Effect of Rolfing Soft Tissue Manipulation and Bowen Technique on Calf Tightness Among Housewives"Rashid Latif Medical CollegeCompletedNot Applicable
NCT07605299Completed
Not Applicable
"Comparative Effect of Rolfing Soft Tissue Manipulation and Bowen Technique on C...Rashid Latif Medical Coll...
NCT07601659
Prospective Italian Validation of SMS in Patients With Suspected Acute StrokeFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07601659Not Yet Recruiting
—
Prospective Italian Validation of SMS in Patients With Suspected Acute StrokeFondazione Policlinico Un...
NCT07604038
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and InflammationKioga Inc.CompletedNot Applicable
NCT07604038Completed
Not Applicable
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived...Kioga Inc.
NCT07602049
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen UniversityRecruitingPhase 2
NCT07602049Recruiting
Phase 2
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen University
NCT07605195
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep LearningYunnan Cancer HospitalNot Yet RecruitingNot Applicable
NCT07605195Not Yet Recruiting
Not Applicable
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Bre...Yunnan Cancer Hospital
NCT07603986
CBT for Anger and Aggression in Children: a Pilot Study of Irritability and SuicidalityChief Scientist, The Israel Ministry of ScienceCompletedNot Applicable
NCT07603986Completed
Not Applicable
CBT for Anger and Aggression in Children: a Pilot Study of Irritability and Suic...Chief Scientist, The Isra...
NCT07603037
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureFirst Affiliated Hospital of Wannan Medical CollegeNot Yet RecruitingNot Applicable
NCT07603037Not Yet Recruiting
Not Applicable
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion...First Affiliated Hospital...
NCT07601269
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.RecruitingEarly Phase 1
NCT07601269Recruiting
Early Phase 1
Replacement of the Native Mitral Valve Using the ReValve SystemReValve Solutions Inc.
NCT07604142
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant PlacementTanta UniversityEnrolling By InvitationNot Applicable
NCT07604142Enrolling By Invitation
Not Applicable
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant...Tanta University
NCT07604207
Multi-organ Imaging of Microvascular and Metabolic FunctionMassachusetts General HospitalNot Yet RecruitingEarly Phase 1
NCT07604207Not Yet Recruiting
Early Phase 1
Multi-organ Imaging of Microvascular and Metabolic FunctionMassachusetts General Hos...
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting3 (15%)
Enrolling by invitation1 (5%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 23 (15%)
Early Phase 12 (10%)
Phase 11 (5%)